Defensive stocks show deep value as cyclicals run hot, UBS says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- Lockheed Martin to acquire Ultra Maritime for $3.45 billion
- Broadcom, Apple extend chip supply deal through 2031
- Strategy reports $8.32B bitcoin loss and sells BTC to fund dividends
Boston Scientific (BSX) PT Raised to $132 at Canaccord Genuity
October 1, 2025 4:10 AM EDTCanaccord Genuity analyst William Plovanic raised the price target on Boston Scientific (NYSE: BSX) to $132.00 (from $131.00) while maintaining a Buy rating.
The analyst comments "Bottom line: BSX outlined its forward growth strategies at its 2025 Investor Day, where the company showed that over the 2026E-2028E period, it expects to continue to... More
